MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.intimp.2026.116784

Медицинская библиотека · International immunopharmacology · 2026

LOXL4 drives radiotherapy resistance and immunosuppression in glioma by targeting SOCS3 for degradation to activate STAT3 signaling.

Du Guo, Ding Zhaojun, Hou Jianxun, Su Qiuyu, Li Qinhong, Xia Xiaohui, Yang Zhao

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Radiotherapy (RT) resistance in glioma is closely linked to abnormal JAK/STAT signaling, but its upstream drivers are unclear. This study investigates the role of lysyl oxidase-like 4 (LOXL4) in this process.

METHODS

LOXL4 expression and its correlation with prognosis and immune infiltration were analyzed using TCGA and CGGA datasets. Stable RT-resistant glioma cell models were established. The functional role of LOXL4 in DNA repair, apoptosis, and pathway activity was assessed. Molecular mechanisms were explored via co-immunoprecipitation (Co-IP) and mass spectrometry. A brain-targeted LOXL4 siRNA nanodelivery system was developed and evaluated in an orthotopic glioma mouse model combined with RT.

RESULTS

LOXL4 is upregulated in high-grade glioma and RT-resistant patients, correlating with poor survival. Mechanistically, LOXL4 promotes the ubiquitination and degradation of suppressor of cytokine signaling 3 (SOCS3). This relieves SOCS3-mediated inhibition of JAK2, leading to sustained STAT3 activation. Consequently, this axis enhances DNA damage repair, inhibits apoptosis, and fosters an immunosuppressive tumor microenvironment. The brain-targeted LOXL4 siRNA nanodelivery system synergized with RT, significantly prolonging survival in glioma-bearing mice.

CONCLUSION

LOXL4 acts as a novel upstream regulator of the JAK/STAT pathway by degrading SOCS3, driving RT resistance and immune remodeling in glioma. Targeting the LOXL4-SOCS3-STAT3 axis with a nanodelivery system presents a promising radiosensitization strategy.

Для цитирования: Du Guo, Ding Zhaojun, Hou Jianxun, Su Qiuyu, Li Qinhong, Xia Xiaohui, Yang Zhao. LOXL4 drives radiotherapy resistance and immunosuppression in glioma by targeting SOCS3 for degradation to activate STAT3 signaling.. International immunopharmacology. 2026. DOI: 10.1016/j.intimp.2026.116784.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.